What’s New in Ontosight® Terminal 1 . 1

What’s New in Ontosight ® Terminal 1.1 A Complete Guide to the Latest Features Welcome to Ontosight ® Terminal, the ultimate research platform for clinical...

Partnering to unlock the true potential of cannabis in medical care

AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering to unlock the potential of phytocannabinoids in designing medical therapies. ES...

Partnering to make 100,000s COVID-19 publications searchable

Michelle Hoiseth, Chief Data Officer for Parexel and Dr. Gunjan Bhardwaj, CEO Innoplexus discuss the importance of access to the latest COVID-19 data. The new C...

Machine learning as an indispensable tool for Biopharma

The cost of developing a new drug roughly doubles every nine years (inflation-adjusted) aka Eroom’s law. As the volume of data for drug discovery a...

Precision medicine and the discovery of biomarkers

In medicine, a Biomarker is a biological indicator, which can mark a state of a biology and is measurable. A Biomarker or a combination of few biomarkers can es...

Accelerate Biomarker Discovery with AI

FDA supports AI for drug development

AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and medical literature. Extensive dat...

How Artificial Intelligence is accelerating research to treat COVID-19

The World Health Organization announced a pandemic in April 2020. Artificial intelligence technologies have presented effective methods for accelerating researc...